Menquadfi 49281-0590-05
Generic: Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, And Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen
- Manufacturer
- Sanofi Vaccines Us Inc.
- Dosage Form
- Injection, Solution
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- April 23, 2020
- Listing Expires
- December 31, 2027
- Application
- BLA125701
Active Ingredients
| Ingredient | Strength |
|---|---|
| Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen | 10 ug/.5mL |
| Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen | 10 ug/.5mL |
| Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen | 10 ug/.5mL |
| Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen | 10 ug/.5mL |
Selected Package
49281-0590-05Selected5 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-05) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)
Other packages for this product(2)
1 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-01) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)
10 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-10) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)
External Resources